ROIV

#518
Roivant Sciences Ltd. - Common Shares
29.9 9 USD
+0.37%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
29.98
30.01
Range Annuel
0.29
32.79
Changement quotidien
+0.37%
Changement Mensuel
+7.53%
Evolution sur 6 mois
+46.43%
Changement Annuel
+63.79%
Clôture Précédente
29.8 8
Open
30.0 1
Low
29.9 8
High
30.0 1
Volume
326
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24 TTM

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Nouvelles